Plus, news about Ming Yu Pharmaceutical, Elpiscience Biopharmaceuticals, Chengdu Olymvax Biopharmaceuticals and Valneva:
🚦 AstraZeneca’s Imfinzi approved for perioperative use in stomach cancers: The PD-L1 inhibitor
↧